Skip to content
On this page:OverviewKey papers
PICO Portalanswers from OpenAlex

Cancer Treatment and Research Communications

JournalCitation impact & published research

Cancer Treatment and Research Communications is a journal indexed in PICO Portal from OpenAlex.

What is the OpenAlex record for Cancer Treatment and Research Communications?

PICO Portalopenalex

The OpenAlex for Cancer Treatment and Research Communications is on the source record.

What are the most-cited papers on Cancer Treatment and Research Communications?

PICO Portalmost cited works
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis
Rebecca Goulding, Matthew Chenoweth, Gebra Cuyún Carter, Mark E. Boye, Kristin M. Sheffield, William J. John, Mark S. Leusch, Catherine E. Muehlenbein, Li Li, Min‐Hua Jen, Adina Rojubally, Jeroen J. Jansen, Eric Druyts
Cancer Treatment and Research Communications. 202063 CitationsOPEN ACCESS
Crizotinib resistance conferred by BRAF V600E mutation in non–small cell lung cancer harboring an oncogenic ROS1 fusion
Shuang Ren, Sisi Huang, Xinqing Ye, Lu-Huai Feng, Lu Yang, Chaonan Zhou, Juan Zhao, Tingting He, Junwei Wang, Bixun Li
Cancer Treatment and Research Communications. 202116 CitationsOPEN ACCESS
Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome
Fedor Moiseenko, Nikita Volkov, A.S. Zhabina, M. Stepanova, N. Rysev, В. В. Клименко, A.V. Myslik, E.V. Artemieva, V.V. Egorenkov, N.H. Abduloeva, Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, Evgeny N. Imyanitov, Vladimir Moiseyenko
Cancer Treatment and Research Communications. 202211 CitationsOPEN ACCESS
The role of dietary components in upper gastrointestinal cancers: A narrative review
Ziba Asheri, Ahmadreza Kolahi, Mahdi Amirpour, Mohammad Gholizadeh
Cancer Treatment and Research Communications. 20260 CitationsOPEN ACCESS

Related on PICO Portal

470M+ articles · 14-day free trial